These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13694112)

  • 41. Experimental and clinical use of intravenous fibrinolysin therapy.
    BOYLES PW
    J Fla Med Assoc; 1960 Apr; 46():1225-8. PubMed ID: 13803597
    [No Abstract]   [Full Text] [Related]  

  • 42. The treatment of some problem cases of thromboembolic disease with fibrinolysin.
    HARLOE JP
    Angiology; 1959 Aug; 10():283-91. PubMed ID: 14399834
    [No Abstract]   [Full Text] [Related]  

  • 43. Human fibrinolysin in the treatment of acute thromboembolic disease.
    ANLYAN WG; WOODHALL B; STICKEL D; MAHALEY MS
    Bull Soc Int Chir; 1962; 21():273-7. PubMed ID: 13861677
    [No Abstract]   [Full Text] [Related]  

  • 44. Fibrinolysin (Actase) in the treatment of peripheral embolism.
    WEBB JA
    J Okla State Med Assoc; 1961 Feb; 54():44-6. PubMed ID: 13783563
    [No Abstract]   [Full Text] [Related]  

  • 45. [Plasmin (fibrinolysin) infusions].
    ROSOLLECK H
    Med Welt; 1961 Oct; 41():2114-8. PubMed ID: 14494137
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapeutic application of fibrinolysin].
    CAMBIER J
    Presse Med (1893); 1960 Feb; 68():319-21. PubMed ID: 13807098
    [No Abstract]   [Full Text] [Related]  

  • 47. [FIBRINOLYSIN, a new agent against thromboembolic disease].
    Prod Pharm; 1959 Sep; 14():502. PubMed ID: 13858182
    [No Abstract]   [Full Text] [Related]  

  • 48. Fibrinolysin as an agent for treatment of thromboembolic accidents.
    CLIFFTON EE
    JAMA; 1961 Jan; 175():302-6. PubMed ID: 13694109
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical and laboratory studies on the fibrinolysin system and is therapeutic use.
    AMBRUS JL; AMBRUS CM; SOKAL JE; MARKUS G; BACK N
    Surg Forum; 1960; 10():426-8. PubMed ID: 13793134
    [No Abstract]   [Full Text] [Related]  

  • 50. Fibrinolysin dissolution of renal pelvic clot post partum.
    GOSPE SM; ZIPSER A; WEIL BJ; FINKLE AL
    N Engl J Med; 1960 Nov; 263():957-9. PubMed ID: 13707360
    [No Abstract]   [Full Text] [Related]  

  • 51. Present status of fibrinolysin therapy.
    GOLLUB S
    SD J Med Pharm; 1961 Jun; 14():217-20. PubMed ID: 13706719
    [No Abstract]   [Full Text] [Related]  

  • 52. The treatment of total hyphemia with fibrinolysin (plasmin). A preliminary report.
    SCHEIE HG; ASHLEY BJ; WEINER A
    Arch Ophthalmol; 1961 Aug; 66():226-31. PubMed ID: 13747411
    [No Abstract]   [Full Text] [Related]  

  • 53. Dose response curves with varying doses of fibrinolysin.
    WILSON WL; NASO F; LIPPMANN E
    Am J Cardiol; 1960 Aug; 6():503-6. PubMed ID: 13845148
    [No Abstract]   [Full Text] [Related]  

  • 54. Fibrinolytic agents.
    CLIFFTON EE
    Med Clin North Am; 1961 Jul; 45():917-33. PubMed ID: 13694110
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of acute thrombophlebitis of the arm after radical mastectomy.
    EVANS JA
    Angiology; 1961 May; 12():155-9. PubMed ID: 13697582
    [No Abstract]   [Full Text] [Related]  

  • 56. [The treatment of vascular thromboses by fibrinolysin. (Results of the first 38 cases)].
    COURBIER R; TORRESANI J; MONTIES JR; HENRY E
    Presse Med (1893); 1962 Nov; 70():2207-8. PubMed ID: 14023411
    [No Abstract]   [Full Text] [Related]  

  • 57. Thrombolytic therapy.
    SHERRY S
    South Med J; 1961 Nov; 54():1287-92. PubMed ID: 13911736
    [No Abstract]   [Full Text] [Related]  

  • 58. Evaluation of the dissolution effect of fibrinolysin (plasmin) on induced vascular microthrombi.
    LEE WH; BRADHAM RR; THREAT B; DAVENPORT C
    Surgery; 1961 Nov; 50():812-6. PubMed ID: 14463579
    [No Abstract]   [Full Text] [Related]  

  • 59. [Experiences in enzymatic wound treatment in surgery].
    FEYE H
    Med Klin; 1961 Oct; 56():1838-40. PubMed ID: 13892682
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of heparin, plasmin, dextran, and low molecular dextran on bioelectrically induced thromboses.
    Flemma RJ; Silver D; Anlyan WG
    Surg Forum; 1965; 16():123-4. PubMed ID: 4220793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.